Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

C9 antibody (AA 74-155) (FITC)

The Rabbit Polyclonal anti-C9 antibody has been validated for . It is suitable to detect C9 in samples from Human.
Catalog No. ABIN7796544

Quick Overview for C9 antibody (AA 74-155) (FITC) (ABIN7796544)

Target

See all C9 Antibodies
C9 (Complement Component C9 (C9))

Reactivity

  • 73
  • 4
  • 2
  • 2
  • 2
  • 2
Human

Host

  • 64
  • 10
  • 2
  • 1
Rabbit

Clonality

  • 57
  • 20
Polyclonal

Conjugate

  • 33
  • 7
  • 6
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This C9 antibody is conjugated to FITC

Application

Please inquire
  • Binding Specificity

    • 16
    • 9
    • 7
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 74-155

    Purpose

    C9 Antibody, FITC conjugated

    Purification

    Protein G purified

    Purity

    >95 %

    Immunogen

    Recombinant Human Complement component C9 protein (74-155AA)

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    C9 (Complement Component C9 (C9))

    Alternative Name

    C9

    Background

    ARMD15 antibody, C9 antibody, C9 deficiency antibody, C9 deficiency with dermatomyositis antibody, C9D antibody, CO9_HUMAN antibody, Complement component 9 antibody, Complement component 9 deficiency antibody, Complement component C9 antibody, Complement component C9b antibody

    UniProt

    P02748

    Pathways

    Complement System
You are here:
Chat with us!